Search

Your search keyword '"Koutroubakis, I."' showing total 254 results
Start Over Author "Koutroubakis, I."
254 results on '"Koutroubakis, I."'

1. A 1-year follow-up study on checkpoint inhibitor-induced colitis: results from a European consortium

Author

Mengoli, C., Aronico, N., Lepore, F., Broglio, G., Merli, S., Natalello, G., Alimenti, E., Scalvini, D., Muscarella, S., Agustoni, F., Pagani, A., Chiellino, S., Corallo, S., Musella, V., Cannizzaro, R., Vecchi, M., Caprioli, F., Gabbiadini, R., Dal Buono, A., Premoli, A., Locati, L.D., Buda, A., Contaldo, A., Schiepatti, A., Biagi, F., Morano, D., Cucè, M., Kotsakis, A., De Lisi, G., Lenti, M.V., Ribaldone, D.G., Borrelli de Andreis, F., Vernero, M., Barberio, B., De Ruvo, M., Savarino, E.V., Kav, T., Blesl, A., Franzoi, M., Gröchenig, H.P., Pugliese, D., Ianiro, G., Porcari, S., Cammarota, G., Gasbarrini, A., Spagnuolo, R., Ellul, P., Foteinogiannopoulou, K., Koutroubakis, I., Argyriou, K., Cappello, M., Jauregui-Amezaga, A., Demarzo, M.G., Silvestris, N., Armuzzi, A., Sottotetti, F., Bertani, L., Festa, S., Eder, P., Pedrazzoli, P., Lasagna, A., Vanoli, A., Gambini, G., Santacroce, G., Rossi, C.M., Delliponti, M., Klersy, C., Corazza, G.R., and Di Sabatino, A.

Published
2024
Full Text
View/download PDF

2. OC.04.7: A ONE-YEAR FOLLOW-UP STUDY ON CHECKPOINT INHIBITORINDUCED COLITIS: RESULTS FROM A EUROPEAN CONSORTIUM

Author

Lenti, M.V., primary, Broglio, G., additional, Ribaldone, D.G., additional, Schiepatti, A., additional, Vernero, M., additional, Cosentino, F., additional, Blesl, A., additional, Buda, A., additional, Croitoru, A., additional, Del Buono, A., additional, Aranzazu Jaurgeu, A., additional, Lasagna, A., additional, Carvalho, D., additional, Pugliese, D., additional, Langholz, E., additional, Dahl, E., additional, Savarino, E.V., additional, Agustoni, F., additional, De Andreis, F. Borrelli, additional, Caprioli, F., additional, Schaik, F., additional, Sottotetti, F., additional, Cammarota, G., additional, Ianiro, G., additional, Gröchenig, H.P., additional, Koutroubakis, I., additional, Geldolf, J., additional, Argyriou, K., additional, Foteinogiannopolou, K., additional, Bertani, L., additional, Lobaton Ortega, T., additional, Cappello, M., additional, Delliponti, M., additional, Demarzo, M.G., additional, Truyens, M., additional, Silvestris, N., additional, Ellul, J., additional, Cannizzaro, R., additional, Gabbiadini, R., additional, Pedrazzoli, P., additional, Spagnuolo, R., additional, Saglio, S., additional, Stroie, T.G., additional, Natalello, G., additional, Varallo, M., additional, La Torre, M.A., additional, Petrucci, C., additional, Klersey, C., additional, Corazza, G.R., additional, and Di Sabatino, A., additional

Published
2024
Full Text
View/download PDF

3. Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus

Author

Abreu, M, Ahuja, V, Allez, M, Ananthakrishnan, A, Bemelman, W, Bernstein, C, Braun, J, Chowers, Y, Colombel, J-F, Danese, S, D'Haens, G, D'Hoore, A, Dignass, A, Dotan, I, Dubinsky, M, Ekbom, A, Fleshner, P, Gasche, C, Gassull, MA, Gearry, R, Ghosh, S, Gibson, P, Griffiths, A, Halfvarson, J, Hanauer, S, Harpaz, N, Hart, A, Hibi, T, Kamm, M, Kaplan, G, Kaser, A, Korelitz, B, Kotze, P, Koutroubakis, I, Kruis, W, Lakatos, P, Lewis, J, Lindsay, J, Loftus, E, Louis, E, Lukas, M, Magro, F, Mahadevan, U, Mantzaris, G, Mary, J-Y, McGovern, D, Moum, B, Munkholm, P, Neurath, M, Ng, S, O'Morain, C, Oresland, T, Panaccione, R, Panes, J, Panis, Y, Pemberton, J, Peyrin-Biroulet, L, Prantera, C, Rachmilewitz, D, Ran, Z, Reinisch, W, Remzi, F, Rhodes, J, Riddell, R, Rogler, G, Rubin, D, Sachar, D, Sandborn, W, Sands, B, Sartor, B, Schoelmerich, J, Schreiber, S, Siegel, C, Siegmund, B, Silverberg, M, Söderholm, J, Sood, A, Spinelli, A, Stange, E, Steinwurz, F, Targan, S, Travis, S, Turner, D, Tysk, C, Vatn, M, Vermeire, S, Watanabe, M, Yamamoto, T, Yamamoto-Furusho, J, Ananthakrishnan, Ashwin N, Kaplan, Gilaad G, Bernstein, Charles N, Burke, Kristin E, Lochhead, Paul J, Sasson, Alexa N, Agrawal, Manasi, Tiong, Jimmy Ho Tuan, Steinberg, Joshua, Kruis, Wolfgang, Steinwurz, Flavio, Ahuja, Vineet, Ng, Siew C, Rubin, David T, Colombel, Jean-Frederic, and Gearry, Richard

Published
2022
Full Text
View/download PDF

7. P663 Efficacy of jak inhibitors in inflammatory bowel disease patients with extraintestinal manifestations– Retrospective study

Author

Livne Margolin, M, primary, González Lama2, Y, additional, Koutroubakis, I, additional, Drygiannakis, I, additional, Shitrit, A, additional, Goldenberg, R, additional, Farkas, K, additional, Molnar, T, additional, Ivány, E, additional, Amiot, A, additional, Carbonnel, F, additional, Girod, P, additional, Doherty, G, additional, Mateescu, B, additional, Ben-Horin1, S, additional, and Kopylov, U, additional

Published
2024
Full Text
View/download PDF

9. P664 Analysis of Clinical Trial Screen Failures in IBD: Real World Results from the IOIBD

Author

Vieujean, S, primary, Lindsay, J O, additional, Rubin, D, additional, D’Amico, F, additional, Ahuja, V, additional, Silverberg, M S, additional, Sood, A, additional, Yamamoto-Furusho, J K, additional, Nagahori, M, additional, Watanabe, M, additional, Koutroubakis, I E, additional, Foteinogiannopoulou, K, additional, Walsh, A, additional, Outtier, A, additional, Abreu, M T, additional, Dubinsky, M, additional, Siegel, C, additional, Louis, E, additional, Dotan, I, additional, Reinisch, W, additional, Danese, S, additional, and Peyrin-Biroulet, L, additional

Published
2023
Full Text
View/download PDF

11. P406 Observational study of the effectiveness of vedolizumab on treatment outcomes and health-related quality of life in biologic-naïve patients with Inflammatory Bowel Diseases in Greece – the TROVE study - Interim Analysis

Author

Chatzinikolaou -, M L, primary, Kifnidi, C, additional, Kokkotis, G, additional, Gatopoulou, A, additional, Michopoulos, S, additional, Soufleris, K, additional, Poulopoulos, G, additional, Theodoropoulou, A, additional, Mantzaris, G, additional, Ntelis, V, additional, Papatheodoridis, G, additional, Tzouvala, M, additional, Koutroubakis, I E, additional, Theocharis, G, additional, Kourikou, A, additional, Christodoulou, D, additional, Grammatopoulos, A, additional, Michalopoulos, G, additional, Georgopoulos, S, additional, Akriviadis, E, additional, Vradelis, S, additional, Gkagkari, V, additional, Zampeli, E, additional, Fasoulas, K, additional, Charalampidis, M, additional, Velegraki, M, additional, Karampekos, G, additional, Viazis, N, additional, Andrianakou, G, additional, Karatzas, P, additional, Tribonias, G, additional, Zacharopoulou, E, additional, Orfanoudaki, E, additional, Tsellou, E, additional, Psyrilos, A, additional, Roussou, D, additional, and Bamias, G, additional

Published
2023
Full Text
View/download PDF

14. Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus

Author

Ananthakrishnan, Ashwin N, primary, Kaplan, Gilaad G, additional, Bernstein, Charles N, additional, Burke, Kristin E, additional, Lochhead, Paul J, additional, Sasson, Alexa N, additional, Agrawal, Manasi, additional, Tiong, Jimmy Ho Tuan, additional, Steinberg, Joshua, additional, Kruis, Wolfgang, additional, Steinwurz, Flavio, additional, Ahuja, Vineet, additional, Ng, Siew C, additional, Rubin, David T, additional, Colombel, Jean-Frederic, additional, Gearry, Richard, additional, Abreu, M, additional, Ahuja, V, additional, Allez, M, additional, Ananthakrishnan, A, additional, Bemelman, W, additional, Bernstein, C, additional, Braun, J, additional, Chowers, Y, additional, Colombel, J-F, additional, Danese, S, additional, D'Haens, G, additional, D'Hoore, A, additional, Dignass, A, additional, Dotan, I, additional, Dubinsky, M, additional, Ekbom, A, additional, Fleshner, P, additional, Gasche, C, additional, Gassull, MA, additional, Gearry, R, additional, Ghosh, S, additional, Gibson, P, additional, Griffiths, A, additional, Halfvarson, J, additional, Hanauer, S, additional, Harpaz, N, additional, Hart, A, additional, Hibi, T, additional, Kamm, M, additional, Kaplan, G, additional, Kaser, A, additional, Korelitz, B, additional, Kotze, P, additional, Koutroubakis, I, additional, Kruis, W, additional, Lakatos, P, additional, Lewis, J, additional, Lindsay, J, additional, Loftus, E, additional, Louis, E, additional, Lukas, M, additional, Magro, F, additional, Mahadevan, U, additional, Mantzaris, G, additional, Mary, J-Y, additional, McGovern, D, additional, Moum, B, additional, Munkholm, P, additional, Neurath, M, additional, Ng, S, additional, O'Morain, C, additional, Oresland, T, additional, Panaccione, R, additional, Panes, J, additional, Panis, Y, additional, Pemberton, J, additional, Peyrin-Biroulet, L, additional, Prantera, C, additional, Rachmilewitz, D, additional, Ran, Z, additional, Reinisch, W, additional, Remzi, F, additional, Rhodes, J, additional, Riddell, R, additional, Rogler, G, additional, Rubin, D, additional, Sachar, D, additional, Sandborn, W, additional, Sands, B, additional, Sartor, B, additional, Schoelmerich, J, additional, Schreiber, S, additional, Siegel, C, additional, Siegmund, B, additional, Silverberg, M, additional, Söderholm, J, additional, Sood, A, additional, Spinelli, A, additional, Stange, E, additional, Steinwurz, F, additional, Targan, S, additional, Travis, S, additional, Turner, D, additional, Tysk, C, additional, Vatn, M, additional, Vermeire, S, additional, Watanabe, M, additional, Yamamoto, T, additional, and Yamamoto-Furusho, J, additional

Published
2022
Full Text
View/download PDF

15. Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases:an International Organization for Study of Inflammatory Bowel Diseases consensus

Author

Ananthakrishnan, A., Kaplan, G., Bernstein, C., Burke, Kristin E., Lochhead, Paul J., Sasson, Alexa N., Agrawal, Manasi, Tiong, Jimmy Ho Tuan, Steinberg, Joshua, Kruis, W., Steinwurz, Flavio, Ahuja, V., Ng, Siew C., Rubin, David T., Colombel, Jean Frederic, Gearry, Richard, Abreu, M., Allez, M., Bemelman, W., Braun, J., Chowers, Y., Colombel, J. F., Danese, S., D'Haens, G., D'Hoore, A., Dignass, A., Dotan, I., Dubinsky, M., Ekbom, A., Fleshner, P., Gasche, C., Gassull, M. A., Ghosh, S., Gibson, P., Griffiths, A., Halfvarson, J., Hanauer, S., Harpaz, N., Hart, A., Hibi, T., Kamm, M., Kaser, A., Korelitz, B., Kotze, P., Koutroubakis, I., Munkholm, P., Ananthakrishnan, A., Kaplan, G., Bernstein, C., Burke, Kristin E., Lochhead, Paul J., Sasson, Alexa N., Agrawal, Manasi, Tiong, Jimmy Ho Tuan, Steinberg, Joshua, Kruis, W., Steinwurz, Flavio, Ahuja, V., Ng, Siew C., Rubin, David T., Colombel, Jean Frederic, Gearry, Richard, Abreu, M., Allez, M., Bemelman, W., Braun, J., Chowers, Y., Colombel, J. F., Danese, S., D'Haens, G., D'Hoore, A., Dignass, A., Dotan, I., Dubinsky, M., Ekbom, A., Fleshner, P., Gasche, C., Gassull, M. A., Ghosh, S., Gibson, P., Griffiths, A., Halfvarson, J., Hanauer, S., Harpaz, N., Hart, A., Hibi, T., Kamm, M., Kaser, A., Korelitz, B., Kotze, P., Koutroubakis, I., and Munkholm, P.

Abstract

Environmental and lifestyle factors play an important role in the natural history of Crohn's disease and ulcerative colitis. A group of international experts from the International Organization for the Study of Inflammatory Bowel Diseases voted on a series of consensus statements to inform the management of inflammatory bowel disease (IBD). The recommendations include avoiding traditional cigarette smoking in patients with Crohn's disease or ulcerative colitis, screening for symptoms of depression, anxiety, and psychosocial stressors at diagnosis and during flares (with referral to mental health professionals when appropriate), and encouraging regular physical activity as tolerated. Patients using dietary approaches for treatment of their IBD should be encouraged to adopt diets that are best supported by evidence and involve monitoring for the objective resolution of inflammation. We recommend formal assessment for obesity and nutritional deficiencies, and patients should be encouraged to maintain a normal body-mass index. A shared decision-making approach to contraception should include the consideration of IBD-related factors, and risk factors for venous thromboembolism. Long-term or frequent use of high-dose non-steroidal anti-inflammatory drugs should be avoided. For primary prevention of disease in the offspring of patients with IBD, we recommend avoiding passive exposure to tobacco, using antibiotics judiciously, and considering breastfeeding when able.

Published
2022

20. P641 Implementation and short-term adverse events of anti-SARS-CoV-2 vaccines in Inflammatory Bowel Disease patients: an international web-based survey

Author

Revés, J, primary, Abreu, B, additional, Chaparro, M, additional, Gisbert, J P, additional, Mariangela, A, additional, Fiorino, G, additional, Barberio, B, additional, Zingone, F, additional, Pisani, A, additional, Cassar, D, additional, Michalopoulos, G, additional, Mantzaris, G, additional, Mountaki, K, additional, Koutroubakis, I, additional, Karmiris, K, additional, Katsanos, K, additional, Ďuricova, D, additional, Burisch, J, additional, Madsen, G R, additional, Maaser, C, additional, Naila, A, additional, Orfanoudaki, E, additional, Milivojevic, V, additional, Buisson, A, additional, Avedano, L, additional, Leone, S, additional, Torres, J, additional, and Ellul, P, additional

Published
2022
Full Text
View/download PDF

23. P677 Patients with Inflammatory Bowel Diseases on anti-TNF treatment have impaired antibody production after Anti-SARS-CoV-2 vaccination: Results from a Panhellenic registry

Author

Zacharopoulou, E, primary, Orfanoudaki, E, additional, Kitsou, V, additional, Tzouvala, M, additional, Tribonias, G, additional, Mantzaris, G J, additional, Viazis, N, additional, Christidou, A, additional, Almpani, F, additional, Karmiris, K, additional, Theodoropoulou, A, additional, Tsafaridou, M, additional, Michopoulos, S, additional, Zampeli, E, additional, Papathanasiou, E, additional, Michalopoulos, G, additional, Tigkas, S, additional, Karatzas, P, additional, Laoudi, E, additional, Liatsos, C, additional, Kyriakos, N, additional, Mylonas, I, additional, Theocharis, G, additional, Koutroubakis, I E, additional, and Bamias, G, additional

Published
2022
Full Text
View/download PDF

24. P235 The natural history of COVID-19 in vaccinated Inflammatory Bowel Disease patients

Author

Viazis, N, primary, Theodoropoulou, A, additional, Zampeli, E, additional, Karmiris, K, additional, Tzouvala, M, additional, Bamias, G, additional, Koutroubakis, I, additional, Liatsos, C, additional, Koustenis, K, additional, Veretanos, C, additional, Papathanasiou, E, additional, Zacharopoulou, E, additional, Tribonias, G, additional, Kitsou, V, additional, Drygiannakis, I, additional, Michopoulos, S, additional, and Mantzaris, G, additional

Published
2022
Full Text
View/download PDF

25. P668 Real world use and adverse events of SARs-CoV-2 vaccination in Greek patients with Inflammatory Bowel Disease

Author

Orfanoudaki, E, primary, Zacharopoulou, E, additional, Kitsou, V, additional, Karmiris, K, additional, Theodoropoulou, A, additional, Mantzaris, G J, additional, Tzouvala, M, additional, Michopoulos, S, additional, Zampeli, E, additional, Michalopoulos, G, additional, Karatzas, P, additional, Viazis, N, additional, Liatsos, C, additional, Bamias, G, additional, and Koutroubakis, I E, additional

Published
2022
Full Text
View/download PDF

32. P124 Gastroenteropancreatic Neuroendocrine Neoplasms in patients with Inflammatory Bowel Disease: An ECCO CONFER Multicentre Case Series

Author

Festa, S, primary, Zerboni, G, additional, Derikx, L, additional, Ribaldone, D G, additional, Dragoni, G, additional, Buskens, C J, additional, Nieveen van Dijkum, E, additional, Pugliese, D, additional, Panzuto, F, additional, Krela-Kaźmierczak, I, additional, Reiss, H, additional, Shitrit, A B G, additional, Chaparro, M, additional, Gisbert, J P, additional, Kopylov, U, additional, Teich, N, additional, Vainer, E, additional, Nagtegaal, I, additional, Hoentjen, F, additional, Garcia, M J, additional, Filip, R, additional, Foteinogiannopoulou, K, additional, Koutroubakis, I, additional, Argollo, M, additional, van Wanrooij, R, additional, Laja, H, additional, Truyens, M, additional, Lobaton Ortega, T, additional, Molnar, T, additional, Savarino, E, additional, Aratari, A, additional, Papi, C, additional, and Goren, I, additional

Published
2021
Full Text
View/download PDF

34. P645 Mental health, work presenteeism and exercise in IBD patients

Author

Sciberras, M, primary, Nascimento, C, additional, Tabone, T, additional, Karmiris, K, additional, Nikolaou, P, additional, Theodoropoulou, A, additional, Mula, A, additional, Goren, I, additional, Yanai, H, additional, Amir, H, additional, Mantzaris, G, additional, Georgiadi, T, additional, Foteinogiannopoulou, K, additional, Koutroubakis, I, additional, Allocca, M, additional, Fiorino, G, additional, Furfaro, F, additional, Katsanos, K H, additional, Fousekis, F, additional, Michalopoulos, G, additional, Torres, J, additional, and Ellul, P, additional

Published
2021
Full Text
View/download PDF

35. P642 Effects of Covid-19 on employment in IBD patients

Author

Sciberras, M, primary, Nascimento, C, additional, Tabone, T, additional, Karmiris, K, additional, Nikolaou, P, additional, Theodoropoulou, A, additional, Mula, A, additional, Goren, I, additional, Yanai, H, additional, Amir, H, additional, Mantzaris, G, additional, Georgiadi, T, additional, Foteinogiannopoulou, K, additional, Koutroubakis, I, additional, Allocca, M, additional, Fiorino, G, additional, Furfaro, F, additional, Katsanos, K H, additional, Fousekis, F, additional, Michalopoulos, G, additional, Torres, J, additional, and Ellul, P, additional

Published
2021
Full Text
View/download PDF

36. Comparison of the Uptake of Screening Colonoscopy between Physicians and the General Population in Greece

Author

Viazis, N. Tzouvala, M. Theodoropoulou, A. Giouleme, O. Thomopoulos, K. Christodoulou, D.K. Michopoulos, S. Soufleris, K. Koutroubakis, I. Karamanolis, G. Papatheodoridis, G. Giotis, I. Paspatis, G. Mantzaris, G.J.

Abstract

Aim: To evaluate the uptake of screening colonoscopy among physicians as compared to the general population. Methods: Asymptomatic physicians, aged 45-67 years, at average risk for colorectal cancer (CRC), working in the participating National Health System hospitals were asked to complete a questionnaire regarding the uptake of screening colonoscopy. The results were compared to those in a background healthy population, aged 50-75 years, inhabitants of a Greek county, who were offered a free access to a screening colonoscopy program for CRC. High-risk adenomas were those ≥10 mm in diameter or any adenoma, regardless of size, with villous histology or high-grade dysplasia. Results: Overall, 267 of 782 physicians and 402 of 6,534 nonphysicians underwent a screening colonoscopy (uptake rates 34.2 and 6.2% respectively, p = 0.00001). Screening colonoscopy has yielded 4 adenocarcinomas (1.6%), 14 high-risk adenomas (5.5%), and 61 low-risk adenomas (25.7%) in the physicians' group. Corresponding figures in the nonphysician arm were 4 (1), 26 (6.5), and 107 (26.6%), respectively. The main reason among physicians for nonadherence was indifference/negligence (n = 213). Conclusion: The proportion of physicians undergoing screening colonoscopy for CRC is significantly higher compared to the general population; however, it does remain suboptimal. © 2019 S. Karger AG, Basel.

Published
2020

37. Interstitial and Granulomatous Lung Disease in Inflammatory Bowel Disease Patients

Author

Eliadou, E., Moleiro, J., Ribaldone, D.G., Astegiano, M., Rothfuss, K., Taxonera, C., Ghalim, F., Carbonnel, F., Verstockt, B., Festa, S., Maia, L., Berrozpe, A., Zagorowicz, E., Savarino, E., Ellul, P., Vavricka, S.R., Calvo, M., Koutroubakis, I., Hoentjen, F., Salazar, L.F., Callela, F., Pizarro, F.C., Soufleris, K., Sonnenberg, E., Cavicchi, M., Wypych, J., Hommel, C., Ghiani, A., Fiorino, G., Eliadou, E., Moleiro, J., Ribaldone, D.G., Astegiano, M., Rothfuss, K., Taxonera, C., Ghalim, F., Carbonnel, F., Verstockt, B., Festa, S., Maia, L., Berrozpe, A., Zagorowicz, E., Savarino, E., Ellul, P., Vavricka, S.R., Calvo, M., Koutroubakis, I., Hoentjen, F., Salazar, L.F., Callela, F., Pizarro, F.C., Soufleris, K., Sonnenberg, E., Cavicchi, M., Wypych, J., Hommel, C., Ghiani, A., and Fiorino, G.

Abstract

Contains fulltext : 220103.pdf (Publisher’s version ) (Closed access), BACKGROUND: Interstitial lung [ILD] disease and granulomatous lung disease [GLD] are rare respiratory disorders that have been associated with inflammatory bowel disease [IBD]. Clinical presentation is polymorphic and aetiology is unclear. METHODS: This was an ECCO-CONFER project. Cases of concomitant ILD or GLD and IBD, or drug-induced ILD/GLD, were collected. The criteria for diagnosing ILD and GLD were based on definitions from the American Thoracic Society and the European Respiratory Society and on the discretion of reporting clinician. RESULTS: We identified 31 patients with ILD. The majority had ulcerative colitis [UC] [n = 22]. Drug-related ILD was found in 64% of these patients, 25 patients [80.6%] required hospitalisation, and one required non-invasive ventilation. The causative drug was stopped in all drug-related ILD, and 87% of patients received systemic steroids. At follow-up, 16% of patients had no respiratory symptoms, 16% had partial improvement, 55% had ongoing symptoms, and there were no data in 13%. One patient was referred for lung transplantation, and one death from lung fibrosis was reported. We also identified 22 GLD patients: most had Crohn's disease [CD] [n = 17]. Drug-related GLD was found in 36% of patients and 10 patients [45.4%] required hospitalisation. The causative drug was stopped in all drug-related GLD, and 81% of patients received systemic steroids. Remission of both conditions was achieved in almost all patients. CONCLUSIONS: ILD and GLD, although rare, can cause significant morbidity. In our series, over half of cases were drug-related and therefore focused pharmacovigilance is needed to identify and manage these cases.

Published
2020

39. Phenotype at diagnosis predicts recurrence rates in Crohn's disease

Author

Wolters, F.L., Russel, M.G., Sijbrandij, J., Ambergen, T., Odes, S., Riis, L., Langholz, E., Politi, P., Qasim, A., Koutroubakis, I., Tsianos, E., Vermeire, S., Freitas, J., van Zeijl, G., Hoie, O., Bernklev, T., Beltrami, M., Rodriguez, D., Stockbrugger, R.W., and Moum, B.

Subjects
Crohn's disease -- Research, Crohn's disease -- Diagnosis, Crohn's disease -- Risk factors, Phenotype -- Research, Phenotype -- Physiological aspects, Health
Published
2006

43. P186 Prevalence and management of anaemia in Greek patients with inflammatory bowel disease: a multicentre real-life cohort study

Author

Karmiris, K, primary, Fotinogiannopoulou, K, additional, Velegraki, M, additional, Koureta, E, additional, Axiaris, G, additional, Kateri, C, additional, Kokkotis, G, additional, Kapizioni, C, additional, Markopoulos, P, additional, Katsoula, A, additional, Gklavas, A, additional, Papaconstantinou, I, additional, Giouleme, O, additional, Tsironi, E, additional, Michalopoulos, G, additional, Bamias, G, additional, Papadopoulos, V, additional, Kapsoritakis, A, additional, Zampeli, E, additional, Michopoulos, S, additional, Karatzas, P, additional, Papatheodoridis, G, additional, Theodoropoulou, A, additional, and Koutroubakis, I E, additional

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results